Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 2020: The SEARCH-AF Trial — Dr Subodh Verma
Author(s): Subodh Verma Added: 3 years ago
Dr Subodh Verma (St Michael's Hospital and Southlake Regional Health Centre, Toronto, CA) discusses the primary results from the SEARCH-AF Cardiolink Randomized Trial (Post-Surgical Enhanced Monitoring for Cardiac Arrhythmias and Atrial Fibrillation). The study examines 396 patients following heart surgery, to assess whether new AF occurrences can be identified using enhanced cardiac rhythm… View more

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
AVATAR: AVR Vs Watchful Waiting in Asymptomatic Severe AS
Author(s): Marko Banovic Added: 2 years ago
In this short video interview, Dr Marko Banovic (Clinical centre of Serbia, Belgrade, RS) discusses the AVATAR Trial. The trial evaluated aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis. Presented first at AHA 2021, the trial showed that early AVR was beneficial at preventing adverse events among patients with asymptomatic… View more

Vascular Disease and Surgery

Intervention
AHA 21: AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism
Author(s): Jeffrey Weitz Added: 2 years ago
Dr Jeffrey Weitz (Thrombosis & Atherosclerosis Research Institute, Ontario, CA) presents the results of the Axiomatic-TKR Study, a phase II dose-ranging study that aims to examine the effect of Milvexian versus Enoxaparin in the treatment of venous thromboembolism in patients undergoing total-knee replacement surgery.The study met its efficacy criteria, where the rate of thromboembolism was… View more

Vascular Disease and Surgery
Author(s): Peter A McCullough Added: 3 years ago
Heart failure (HF) is a common condition and carries a considerable age-dependent all-cause mortality. As a leading cause of hospitalization in adults, ~50% of patients discharged with a diagnosis of HF are readmitted within six months, and the one-year mortality rate is 20% after an initial diagnosis is established. There is currently a chronic HF epidemic with a rapidly expanding prevalence… View more

Imaging & Diagnostics

MI/ACS
View from the Thoraxcenter: AHA 21 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
Learn more about of the top AHA 2021 late-breaking trialswith View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and DrJoost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL). In this short summary video, they summarise the take-home messages and share their take on how the data will shape patient care and research. Trials covered in detail include: • Aortic Valve Replacement versus… View more

Vascular Disease and Surgery

Standards & Guidelines
Author(s): Peter A McCullough Added: 3 years ago
Heart failure (HF) is a common condition and carries a considerable age-dependent all-cause mortality.1 As a leading cause of hospitalization in adults, ~50% of patients discharged with a diagnosis of HF are readmitted within six months, and the one-year mortality rate is 20% after an initial diagnosis is established. There is currently a chronic HF epidemic with a rapidly expanding prevalence… View more

Prevention & Chronic Conditions
Major Cardiovascular Advances: Highlights from the 2019 American College of Cardiology Annual Scientific Session
Author(s): Hisham A Badreldin , Khalid bin Saleh , Majed Al-Yami Added: 3 years ago
WRAP-IT The Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT) was a prospective multicenter study to determine the safety and efficacy of an absorbable surgical mesh envelope containing two antibiotics (minocycline and rifampin) in reducing infection incidence in patients with cardiac implantable electronic devices compared to standard care.1 Approximately 7,000… View more

Prevention & Chronic Conditions
Supraventricular Tachycardia: Which Patient Should be Treated with Radiofrequency Ablation?
Author(s): Etienne Delacrétaz Added: 3 years ago
Catheter ablation of SVT has emerged as a curative treatment with high success rates and plays a central role in the management of supraventricular tachycardia (SVT).This short review aims to give an update on the outcomes of catheter ablation and provide a guide to appropriate decision making in patients with SVT. Mechanisms of SVT Tachycardias can be categorized as ventricular (involving the… View more

Electrophysiology & Arrhythmia
Author(s): James L Januzzi Added: 3 years ago
The use of natriuretic peptide testing has dramatically risen recently, in recognition of the value of these blood tests for assisting in the evaluation of patients with suspected heart failure (HF). B-type natriuretic peptide (BNP) is formed as a consequence of production of a 108-amino-acid precursor peptide that is synthesised within the cardiomyocyte; this 'pro-BNP108' is subsequently cleaved… View more

Heart Failure

Prevention & Chronic Conditions
Author(s): James L Januzzi Added: 3 years ago
The use of natriuretic peptide testing has dramatically risen recently, in recognition of the value of these blood tests for assisting in the evaluation of patients with suspected heart failure (HF). B-type natriuretic peptide (BNP) is formed as a consequence of production of a 108-amino-acid precursor peptide that is synthesised within the cardiomyocyte; this 'pro-BNP108' is subsequently cleaved… View more

Imaging & Diagnostics

Heart Failure